# Efficacy and Safety of Cordyceps Sinensis Mycelium Culture Extract(Paecilomyces Hepiali, CBG-CS-2) on Promotion of Immunity

> **NCT02244372** · NA · COMPLETED · sponsor: **Chonbuk National University Hospital** · enrollment: 90 (actual)

## Conditions studied

- Immunity

## Interventions

- **DIETARY_SUPPLEMENT:** Cordyceps sinensis mycelium culture extract 0.76 g
- **DIETARY_SUPPLEMENT:** Cordyceps sinensis mycelium culture extract 1.15 g
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT02244372
- **Lead sponsor:** Chonbuk National University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2014-09
- **Final completion:** 2015-02
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2019-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02244372

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02244372, "Efficacy and Safety of Cordyceps Sinensis Mycelium Culture Extract(Paecilomyces Hepiali, CBG-CS-2) on Promotion of Immunity". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02244372. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*